Search Ontology:
ChEBI

dorzolamide

Term ID
CHEBI:4702
Synonyms
  • (4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
  • (4S,6S)-4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide
  • (4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide
  • (4S-TRANS)-4-(ETHYLAMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO(2,3-B)THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDE
  • 4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide
  • 4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide
  • 4S,6S-dorzolamide
  • Dorzolamide
Definition
5,6-Dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide in which hydrogens at the 4 and 6 positions are substituted by ethylamino and methyl groups, respectively (4S, trans-configuration). A carbonic anhydrase inhibitor, it is used as the hydrochloride in ophthalmic solutions to lower increased intraocular pressure in the treatment of open-angle glaucoma and ocular hypertension.
References
  • beilstein:5910880
  • cas:120279-96-1
  • drugbank:DB00869
  • drugcentral:949
  • kegg.compound:C06969
  • kegg.drug:D07871
  • lincs.smallmolecule:LSM-5597
  • patent:EP296879
  • patent:US4797413
  • pdb-ccd:ETS
  • pubmed:10762051
  • pubmed:11229775
  • pubmed:11425561
  • pubmed:11906288
  • pubmed:14611846
  • pubmed:14684332
  • wikipedia.en:Dorzolamide
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from dorzolamide
Phenotype where environments contain dorzolamide
Phenotype modified by environments containing dorzolamide
Phenotype affecting dorzolamide
Human Disease Model